The case was seen as a test of a more aggressive policy by the agency.
Related Posts
Curium Strikes $8 Billion Mega-Deal for Lantheus to Forge Global Radiopharmaceutical Powerhouse
In a definitive move to dominate the rapidly expanding nuclear medicine landscape, Curium US Holdings has entered into a definitive agreement to acquire Lantheus Holdings, Inc. (NASDAQ: LNTH) for a...
AstraZeneca Shares Tumble on Reports of $400 Billion Bristol Myers Squibb Merger Talks
AstraZeneca PLC (LON: AZN) shares fell as much as 7% in London trading on Monday, August 3, 2026, following reports that the British pharmaceutical giant has held preliminary discussions regarding a...
Biogen Shifts M&A Strategy as Apellis Acquisition Pushes Revenue Above Analyst Expectations
CAMBRIDGE, Mass. — Biogen Inc. (NASDAQ: BIIB) has signaled a definitive pivot in its capital allocation strategy following a blockbuster second quarter that saw the company swing from a projected...
Bayer Bolsters Ophthalmology Portfolio with $2.45 Billion Acquisition of Perfuse Therapeutics
TL;DR Bayer AG announced on May 6, 2026, its acquisition of Perfuse Therapeutics for up to $2.45 billion, including a $300 million upfront payment and $2.15 billion in milestones. The deal secures...